-
1Academic Journal
المؤلفون: Xiujiang Sun, Peng Li, Xiaoyi Qu, Wenguang Liu
المصدر: Pharmaceutical Biology, Vol 59, Iss 1, Pp 1326-1333 (2021)
مصطلحات موضوعية: inflammatory factors, pathological changes, tlr4 inhibitor, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
2Academic Journal
المؤلفون: Snigdha Samarpita, Joo Young Kim, Mahaboob Khan Rasool, Kyoung Soo Kim
المصدر: Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-10 (2020)
مصطلحات موضوعية: TLR4 inhibitor, TAK-242 (resatorvid), Rheumatoid arthritis (RA), Damage-associated molecular patterns (DAMPs), Lipopolysaccharide (LPS), Poly(I:C), Diseases of the musculoskeletal system, RC925-935
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1478-6362
-
3Academic Journal
المؤلفون: Mohammad Asif Sherwani, Ahmed Abdelgawad, Minh Chung, Saad Ibrahim, Mualla Eraslan, Craig A. Elmets, Nabiha Yusuf
المصدر: Cancers; Volume 13; Issue 21; Pages: 5406
مصطلحات موضوعية: ultraviolet radiation, TLR4 inhibitor, skin cancer, DNA repair, immune response
وصف الملف: application/pdf
Relation: Cancer Therapy; https://dx.doi.org/10.3390/cancers13215406
-
4
المؤلفون: Xiaoyi Qu, Xiujiang Sun, Peng Li, Wenguang Liu
المصدر: Pharmaceutical Biology, Vol 59, Iss 1, Pp 1326-1333 (2021)
Pharmaceutical Biology
article-version (VoR) Version of Recordمصطلحات موضوعية: Male, Necrosis, Antioxidant, medicine.medical_treatment, Inflammatory arthritis, Isovitexin, Anti-Inflammatory Agents, Pharmaceutical Science, Inflammation, Context (language use), RM1-950, Pharmacology, Antioxidants, Rats, Sprague-Dawley, chemistry.chemical_compound, inflammatory factors, Drug Discovery, medicine, Animals, Colchicine, tlr4 inhibitor, Apigenin, Sulfonamides, Arthritis, Gouty, NF-kappa B, General Medicine, medicine.disease, Rats, Gout, Toll-Like Receptor 4, Disease Models, Animal, pathological changes, Complementary and alternative medicine, chemistry, Myeloid Differentiation Factor 88, Molecular Medicine, Therapeutics. Pharmacology, medicine.symptom, Research Article
-
5
المؤلفون: Kyoung Soo Kim, Snigdha Samarpita, Joo Young Kim, Mahaboobkhan Rasool
المصدر: Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-10 (2020)
Arthritis Research & Therapyمصطلحات موضوعية: 0301 basic medicine, musculoskeletal diseases, medicine.medical_specialty, lcsh:Diseases of the musculoskeletal system, Poly(I:C), Arthritis, Lipopolysaccharide (LPS), Pharmacology, Pathogenesis, Arthritis, Rheumatoid, 03 medical and health sciences, 0302 clinical medicine, Damage-associated molecular patterns (DAMPs), Internal medicine, medicine, Animals, Humans, Rats, Wistar, Receptor, Cells, Cultured, TAK-242 (resatorvid), Toll-like receptor, Sulfonamides, Fibroblast-like synoviocytes (FLS), business.industry, TLR4 inhibitor, medicine.disease, Arthritis, Experimental, Synoviocytes, Rheumatology, Rats, Toll-Like Receptor 4, 030104 developmental biology, Rheumatoid arthritis, Antirheumatic Agents, Rheumatoid arthritis (RA), TLR3, TLR4, Adjuvant-induced arthritis (AIA) rat model, Female, lcsh:RC925-935, business, 030217 neurology & neurosurgery, Research Article
-
6Academic Journal
المؤلفون: Michalska, Patrycja, Buendía Abaitua, Izaskun, Duarte, Pablo, Fernández-Mendívil, Cristina, Negredo, Pilar, Cuadrado, Antonio, López, Manuela G., León, Rafael
المساهمون: Instituto de Salud Carlos III, Fundación "la Caixa", Comunidad de Madrid, Agencia Estatal de Investigación (España), Ministerio de Ciencia, Innovación y Universidades (España), Ministerio de Educación, Cultura y Deporte (España), Instituto Fundación Teófilo Hernando, European Commission, Ministerio de Economía y Competitividad (España)
مصطلحات موضوعية: Neuroinflammation, Neurodegenerative diseases, MD2 antagonist, TLR4 inhibitor, Antiinflammatory properties, Multi-target
Relation: #PLACEHOLDER_PARENT_METADATA_VALUE#; B2017/BMD-3827/NRF24AD-CM; info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-095793-B-I00; RTI2018-095793-B-I00/AEI/10.13039/501100011033; info:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/FJCI-2016/28282; https://doi.org/10.1016/j.phrs.2019.104597; Sí; Pharmacological Research 152: 104597 (2020); http://hdl.handle.net/10261/222261; http://dx.doi.org/10.13039/501100000780; http://dx.doi.org/10.13039/501100004587; http://dx.doi.org/10.13039/501100003329; http://dx.doi.org/10.13039/501100003176; http://dx.doi.org/10.13039/100012818; http://dx.doi.org/10.13039/501100011033
الاتاحة: http://hdl.handle.net/10261/222261
https://doi.org/10.1016/j.phrs.2019.104597
https://doi.org/10.13039/501100000780
https://doi.org/10.13039/501100004587
https://doi.org/10.13039/501100003329
https://doi.org/10.13039/501100003176
https://doi.org/10.13039/100012818
https://doi.org/10.13039/501100011033 -
7Electronic Resource
المؤلفون: Instituto de Salud Carlos III, Fundación la Caixa, Comunidad de Madrid, Agencia Estatal de Investigación (España), Ministerio de Ciencia, Innovación y Universidades (España), Ministerio de Educación, Cultura y Deporte (España), Instituto Fundación Teófilo Hernando, European Commission, Ministerio de Economía y Competitividad (España), Michalska, Patrycja, Buendía Abaitua, Izaskun, Duarte, Pablo, Fernández-Mendívil, Cristina, Negredo, Pilar, Cuadrado, Antonio, López, Manuela G., León, Rafael
مصطلحات الفهرس: Neuroinflammation, Neurodegenerative diseases, MD2 antagonist, TLR4 inhibitor, Antiinflammatory properties, Multi-target, artículo
URL:
http://hdl.handle.net/10261/222261 https://doi.org/10.1016/j.phrs.2019.104597 https://doi.org/10.1016/j.phrs.2019.104597
Sí
B2017/BMD-3827/NRF24AD-CM
info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-095793-B-I00
RTI2018-095793-B-I00/AEI/10.13039/501100011033
info:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/FJCI-2016/28282